ArticleClinical and experimental otorhinolaryngology2026
Treatment Outcomes of the Inferior Meatus Augmentation Procedure With Autologous Costal Cartilage for Empty Nose Syndrome.
Article in Clinical and experimental otorhinolaryngology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Evidence-based approaches for Empty Nose Syndrome management: a systematic review highlighting current treatments and future directions.Frontiers in bioengineering and biotechnology · 2026Pooled it
- Nasal Septal Perforation: A Potential Pitfall in Cotton Testing for Suspected Empty Nose Syndrome-A Case Series and Staged Algorithm.International forum of allergy & rhinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
objectivesEmpty nose syndrome (ENS) is a rare postoperative complication that can develop following turbinate surgery. Here, we present our clinical experience and a comprehensive analysis of the inferior meatus augmentation procedure with autologous costal cartilage (IMAP-ACC) as a treatment for ENS.
methodsWe retrospectively reviewed the medical records of patients diagnosed with ENS who underwent IMAP-ACC at a tertiary referral center between November 2015 and November 2023. Symptom improvement was evaluated using the Empty Nose Syndrome 6-Item Questionnaire (ENS6Q) score before and after the procedure. In addition, perioperative complications and instances of revision surgery were systematically examined.
resultsOf the 32 patients who underwent IMAP-ACC, clinical analysis included 20 patients (16 men, 4 women) with a mean age of 39.1±11.5 years and a mean follow-up duration of 61.2±28.8 months. The mean ENS6Q score significantly improved from 17.5±5.3 preoperatively to 9.1±6.0 at the final follow-up (P<0.001). In a subgroup analysis of 16 patients with available early follow-up data, significant reductions in ENS6Q scores were observed both at early follow-up (7.8±5.7) and long-term follow-up (8.6±6.5), compared to the preoperative value (18.2±5.6). Across all 32 patients, nasal obstruction was the most common perioperative complication (34.4%), necessitating reoperation in four patients (12.5%). The majority of complications were effectively managed with a conservative approach.
conclusionIMAP-ACC has proven to be a valuable and durable treatment option for patients with ENS, demonstrating sustained symptom improvement over extended follow-up periods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.